Search results
Results from the WOW.Com Content Network
The Rotterdam Study or ERGO (Dutch: Erasmus Rotterdam Gezondheid Onderzoek) is a prospective, population-based cohort study. The aim of the Rotterdam Study is to investigate etiology , preclinical phase, prognosis and potential intervention targets of chronic diseases in mid- and late-life.
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer
Version 3.0 also included drug transporter data, drug pathway data, drug pricing, patent and manufacturing data as well as data on >5000 experimental drugs. Version 4.0 was released in 2014. [ 4 ] This version included 1558 FDA-approved small molecule drugs, 155 biotech drugs and 4200 unique drug targets.
A deelgemeente (Dutch pronunciation: [ˈdeːlɣəˌmeːntə] ⓘ, literally sub-municipality), or section (French pronunciation: ⓘ), is a subdivision of a municipality in Belgium and, until March 2014, in the Netherlands as well.
epocrates is a widely used mobile medical reference application that provides healthcare professionals with access to clinical information at the point of care. The software is designed to assist physicians, pharmacists, nurse practitioners, physician assistants and other healthcare providers in making informed decisions about drug interactions, medical calculations, diagnosis and treatment ...
The drug carrier releases the anti-cancer drug when triggered by the tumor's low pH levels and these pH levels control the rate of drug release. [16] Drugs administered usually require frequent dosing, but with a drug delivery carrier, it allows for a gradual and sustained release of the drug leading cancer patients to not have to be in the ...
To reduce your risk of developing side effects or drug interactions, it’s important to inform your healthcare provider about your medical history and your current or recent use of any drugs or ...
Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication used to treat a number of types of cancer. [2] This includes melanoma, lung cancer, malignant pleural mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver cancer, gastric cancer, and esophageal or gastroesophageal ...